Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 47,359 | 1,987 | N/A |
| TOTAL | $48,274 | $2,448 | $N/A |
| Non-Current Assets | |||
| PPE Net | 1,482 | 1,404 | N/A |
| Other Non-Current Assets | 169 | 283 | 0 |
| TOTAL | $1,651 | $1,687 | $N/A |
| Total Assets | $49,925 | $4,135 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 1,704 | 708 | N/A |
| Accounts payable and accrued liabilities | 814 | 1,414 | 0 |
| Accrued Expenses | 3,810 | 866 | N/A |
| Other current liabilities | 298 | 24 | N/A |
| TOTAL | $6,764 | $3,153 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 7,703 | 2,274 | N/A |
| Deferred Revenues | 138 | 141 | N/A |
| Other Non-Current Liabilities | 29 | 67 | 0 |
| TOTAL | $7,732 | $2,478 | $N/A |
| Total Liabilities | $14,496 | $5,631 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 2 | 1 | N/A |
| Retained earnings | -82,206 | -41,921 | N/A |
| Other shareholders' equity | 114,811 | 39,958 | 0 |
| TOTAL | $35,429 | $-1,496 | $N/A |
| Total Liabilities And Equity | $49,925 | $4,135 | $0 |